Withrow, 1993 - Google Patents
Dosimetry, field shaping and other considerations for intra-operativeWithrow, 1993
- Document ID
- 7146710450976084216
- Author
- Withrow S
- Publication year
- Publication venue
- Handbook of Dosimetry Data for Radiotherapy
External Links
Snippet
157. McCullough, EC and Anderson JA, The dosimetric properties of an application system for intraoperative electron-beam therapy utilizing a Clinac-18 accelerator, Med. Phys., 9, 261, 1982. 158. McCullough, EC and Gunderson, LL, Energy as well as applicator size and …
- 238000004980 dosimetry 0 title description 39
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1024—Seeds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1014—Intracavitary radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1002—Intraluminal radiation therapy
- A61N2005/1004—Intraluminal radiation therapy having expandable radiation sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1075—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4510924A (en) | Brachytherapy devices and methods employing americium-241 | |
| US6551232B1 (en) | Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof | |
| Williamson | Brachytherapy technology and physics practice since 1950: a half-century of progress | |
| Nath et al. | Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 | |
| Nath et al. | Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sources | |
| US4702228A (en) | X-ray-emitting interstitial implants | |
| Williamson | Monte Carlo evaluation of specific dose constants in water for 125I seeds | |
| Mason et al. | Ytterbium‐169: Calculated physical properties of a new radiation source for brachytherapy | |
| Nath et al. | Dosimetric characteristics of a double wall 125I source for interstitial brachytherapy | |
| Sadeghi et al. | Dosimetric characteristics of the brachytherapy sources based on Monte Carlo method | |
| USH669H (en) | Samarium-145 and its use as a radiation source | |
| Wierzbicki et al. | Calculated dosimetric parameters of the IoGold 125I source model 3631‐A | |
| Luxton et al. | Measurement of dose rate from exposure-calibrated 125I seeds | |
| Meigooni | Dosimetry of interstitial brachytherapy sources: recommendations | |
| Nath | New directions in radionuclide sources for brachytherapy | |
| Alshreef et al. | Validation of GAMOS Monte Carlo simulation for 131Cs brachytherapy source in water and dosimetric characterization of solid water, bone, and brain tissues | |
| Nath et al. | A dose computation model for 241Am vaginal applicators including the source‐to‐source shielding effects | |
| Jung et al. | Dosimetric characterization of 142Pr glass seeds for brachytherapy | |
| Withrow | Dosimetry, field shaping and other considerations for intra-operative | |
| Shih et al. | Neutron induced brachytherapy: a combination of neutron capture therapy and brachytherapy | |
| Burger | Radioactive sources in brachytherapy | |
| Li | Physics and clinical aspects of brachytherapy | |
| Jones et al. | Calibration and Quality Assurance of Sources | |
| Jung | 142Pr glass seeds for the brachytherapy of prostate cancer | |
| SHALEK et al. | THE DOSIMETRY OF IONIZING RADIATION, VOL. III |